EcoDrugPlus

Solute Carrier Family 5 Member 1

Ensembl ID : ENSGACG00000017252
Gene Symbol: SLC5A1
1 Cross references
249 Possible Orthologues:

Solute Carrier Family 5 Member 1

Ensembl ID : ENSGACG00000017262
Gene Symbol: SLC5A1
1 Cross references
249 Possible Orthologues:

Solute Carrier Family 5 Member 2

Ensembl ID : ENSGACG00000005825
Gene Symbol: SLC5A2
1 Cross references
199 Possible Orthologues:

Solute Carrier Family 6 Member 1a

Ensembl ID : ENSGACG00000015157
Gene Symbol: SLC6A1A
1 Cross references
204 Possible Orthologues:

Solute Carrier Family 6 Member 1b

Ensembl ID : ENSGACG00000007265
Gene Symbol: SLC6A1B
1 Cross references
208 Possible Orthologues:

Solute Carrier Family 6 Member 2

Ensembl ID : ENSGACG00000016637
Gene Symbol: SLC6A2
1 Cross references
204 Possible Orthologues:

Solute Carrier Family 6 Member 3

Ensembl ID : ENSGACG00000006614
Gene Symbol: SLC6A3
1 Cross references
167 Possible Orthologues:

Solute Carrier Family 6 Member 4a

Ensembl ID : ENSGACG00000006192
Gene Symbol: SLC6A4A
1 Cross references
203 Possible Orthologues:

Solute Carrier Family 6 Member 9

Ensembl ID : ENSGACG00000014462
Gene Symbol: SLC6A9
1 Cross references
207 Possible Orthologues:

Solute Carrier Family 9 Member A3, Tandem Duplicate 2

Ensembl ID : ENSGACG00000002446
Gene Symbol: SLC9A3.2
1 Cross references
236 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSGACG00000011189
Gene Symbol: SSTR2
2 Cross references
192 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSGACG00000005479
Gene Symbol: SSTR2
2 Cross references
192 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).